Hereditary Cancer Test Plus – RAPID

Test Code
SLS160032

What is the Hereditary Cancer Test Plus - RAPID?

The Hereditary Cancer Test Plus – Rapid is an expedited version of our comprehensive NGS-based test, analyzing 137 genes associated with inherited cancer risk and including digital MLPA for 28 clinically relevant genes. It delivers faster results without compromising on the depth or quality of genetic analysis. The test covers all genes recommended by ACMG guidelines and uses a peripheral blood sample.

Genes Covered/No of Genes: 137 Genes

Indications for Testing

  • Urgent clinical need for genetic information to guide surgical or treatment decisions
  • A personal or family history of early-onset or multiple cancers
  • Suspected hereditary cancer syndromes requiring rapid risk assessment
  • Patients with newly diagnosed cancers where timely genetic input can impact management

Why is This Test Important?

With integrated digital MLPA and a faster turnaround time, this test provides critical genetic insights when time-sensitive decisions are needed for cancer care or prevention.
All Hereditary Cancers, Comprehensive Hereditary Test

Contact Us